On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH) study using the Starling Fluid Management Monitoring System, recently published in CHEST. Performed at 13 hospitals across the U.S. and UK, the FRESH study demonstrated lower net fluid balance, reduced mechanical ventilation and reduced kidney injury in septic shock patients when a non-invasive dynamic assessment is used to guide intravenous (IV) fluid and vasopressor administration.

Septic shock is a common, life-threatening condition that can develop due to a bacterial or viral infection, including respiratory viruses like influenza or SARS-CoV-2. Every year, it affects an estimated 47 million people globally and results in at least 11 million deaths